PT1071438E - Preparacao estabilizada de virus de herpes - Google Patents

Preparacao estabilizada de virus de herpes

Info

Publication number
PT1071438E
PT1071438E PT99919380T PT99919380T PT1071438E PT 1071438 E PT1071438 E PT 1071438E PT 99919380 T PT99919380 T PT 99919380T PT 99919380 T PT99919380 T PT 99919380T PT 1071438 E PT1071438 E PT 1071438E
Authority
PT
Portugal
Prior art keywords
virus
herpes viruses
stabilized preparation
stabilized
aminoacids
Prior art date
Application number
PT99919380T
Other languages
English (en)
Inventor
Claire Alison Varley
Peter Thomas Loudon
Original Assignee
Cantab Pharmaceuticals Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Pharmaceuticals Res Ltd filed Critical Cantab Pharmaceuticals Res Ltd
Publication of PT1071438E publication Critical patent/PT1071438E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT99919380T 1998-04-24 1999-04-26 Preparacao estabilizada de virus de herpes PT1071438E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9808922A GB9808922D0 (en) 1998-04-24 1998-04-24 Virus preparations

Publications (1)

Publication Number Publication Date
PT1071438E true PT1071438E (pt) 2004-11-30

Family

ID=10831020

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99919380T PT1071438E (pt) 1998-04-24 1999-04-26 Preparacao estabilizada de virus de herpes

Country Status (12)

Country Link
US (1) US6258362B1 (pt)
EP (1) EP1071438B1 (pt)
JP (1) JP2002512970A (pt)
AT (1) ATE269712T1 (pt)
AU (1) AU3718299A (pt)
CA (1) CA2329000C (pt)
DE (1) DE69918283T2 (pt)
DK (1) DK1071438T3 (pt)
ES (1) ES2224646T3 (pt)
GB (1) GB9808922D0 (pt)
PT (1) PT1071438E (pt)
WO (1) WO1999055348A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19803453A1 (de) * 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
US20040022800A1 (en) * 2000-07-31 2004-02-05 Mark Parrington Respiratory syncytial virus vaccine
US7101693B2 (en) 2001-09-07 2006-09-05 Brigham Young University Plasticized hydrophilic glasses for improved stabilization of biological agents
BR0214822A (pt) * 2001-12-10 2004-12-14 Bavarian Nordic As Formulações contendo poxvìrus e processo para preparar composições contendo poxvìrus estáveis
AU2008201215B2 (en) * 2001-12-10 2010-11-18 Bavarian Nordic A/S Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
OA13033A (en) * 2003-02-20 2006-11-10 Ct Nat De Investigaciones Cientificas Attenuated strains of Vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination.
CA2552328A1 (en) * 2004-01-15 2005-08-04 Intervet International B.V. Non-animal origin stabilizers and processes for producing the same
CA2571261C (en) * 2004-06-29 2018-08-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Safer attenuated virus vaccines with missing or diminished latency of infection
WO2006052813A2 (en) * 2004-11-05 2006-05-18 Wellstat Biologics Corporation Stable and filterable enveloped virus formulations
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
CA2616826A1 (en) * 2005-08-04 2007-02-15 Wyeth Stabilizers for veterinary vaccines
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
US10166285B2 (en) 2006-11-09 2019-01-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Recombinant virus with diminished latency and methods of using same
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing
WO2010044365A1 (ja) * 2008-10-17 2010-04-22 国立大学法人東京海洋大学 鮮度測定用試薬キット
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
RU2567668C2 (ru) * 2009-05-26 2015-11-10 Эдванст Бионутришн Корпорейшн Стабильная сухая порошкообразная композиция, содержащая биологически активные микроорганизмы и/или биоактивные материалы, и способ ее изготовления
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RS57588B1 (sr) 2010-08-13 2018-11-30 Advanced Bionutrition Corp Supstanca za stabilizaciju bioloških materijala za suvo skladištenje
CN101972474B (zh) * 2010-11-11 2012-06-27 长春祈健生物制品有限公司 冻干带状疱疹减毒活疫苗及制备方法
US9045728B2 (en) 2010-12-02 2015-06-02 Oncolytics Biotech Inc. Liquid viral formulations
WO2012075376A2 (en) * 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Lyophilized viral formulations
EP3246400B1 (en) 2012-01-09 2019-10-23 Sanofi Pasteur Biologics, LLC Purification of herpes virus
CA2873775C (en) 2012-05-21 2021-04-20 Sanofi Pasteur Limited Herpesvirus compositions and related methods
FR3024780B1 (fr) * 2014-08-07 2018-11-30 Bertin Pharma Reactif pret a l'emploi
WO2017019273A1 (en) 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Stable dry probiotic compositions for special dietary uses
GB201701239D0 (en) * 2017-01-25 2017-03-08 Glaxosmithkline Biologicals Sa Novel formulation
US20220193222A1 (en) * 2018-11-30 2022-06-23 Vaccine Stabilization Institute Viral formulations containing amino acids

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE209738C (pt)
GB960850A (en) * 1961-09-08 1964-06-17 Wellcome Found Measles virus vaccine
JPS4848621A (pt) * 1971-10-20 1973-07-10
JPS4868730A (pt) * 1971-12-21 1973-09-19
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
JPS5648488B2 (pt) * 1973-06-06 1981-11-16
JPS5341202B2 (pt) * 1974-03-12 1978-11-01
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
AU532186B2 (en) * 1978-07-21 1983-09-22 Merck & Co., Inc. Herpes virus vaccine
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
JPS5775929A (en) * 1980-08-28 1982-05-12 Merck & Co Inc Freeze drying method
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
HU183765B (en) * 1981-12-23 1984-05-28 Phylaxia Oltoanyagtermeloe Process for producing lyophilized vaccine against duck hepatitis
DK331087A (da) 1986-06-30 1987-12-31 Smith Kline Rit Stabilisator for levende vaccine
JPS63230851A (ja) * 1987-03-20 1988-09-27 Sumitomo Metal Ind Ltd 耐食性に優れた油井管用低合金鋼
IL86180A (en) 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
DD299213A7 (de) * 1988-05-04 1992-04-09 Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De Verfahren zur stabilisierung eines lebendvirusimpfstoffes gegen temperatureinwirkung
FR2633518B1 (fr) 1988-06-30 1991-03-22 Merieux Inst Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues
KR100372934B1 (ko) 1990-09-25 2003-12-24 캔탑 파마슈티칼스 리서취 리미티드 형질 상보성 세포주에 의해 생성된 바이러스 결손 백신
US5665362A (en) * 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
US5837261A (en) * 1990-09-25 1998-11-17 Cantab Pharmaceuticals Research Limited Viral vaccines
AU673827B2 (en) 1992-03-24 1996-11-28 United Cancer Research Institute Vaccine containing live virus for therapy of viral diseases and malignancies
JPH06234659A (ja) 1992-05-05 1994-08-23 Handai Biseibutsubiyou Kenkyukai 安定化生ワクチン
UA27137C2 (uk) * 1992-06-04 2000-02-28 Мерк Енд Ко., Інк. Спосіб одержаhhя вакциhи hа осhові живого атеhуйов
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
AU696336B2 (en) 1993-03-19 1998-09-10 Cantab Pharmaceuticals Research Limited Defective mutant non-retroviral virus (e.g. HSV) as vaccine
CA2158935A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
US5869306A (en) 1995-03-17 1999-02-09 Hisamitsu Pharmaceutical Co., Inc. Gene transfer preparation
EP0946193A1 (en) 1996-12-20 1999-10-06 Merck & Co., Inc. Stabilizers for lyophilized vaccines

Also Published As

Publication number Publication date
EP1071438A2 (en) 2001-01-31
US6258362B1 (en) 2001-07-10
WO1999055348A3 (en) 1999-12-16
CA2329000C (en) 2010-03-23
WO1999055348A2 (en) 1999-11-04
EP1071438B1 (en) 2004-06-23
GB9808922D0 (en) 1998-06-24
JP2002512970A (ja) 2002-05-08
ES2224646T3 (es) 2005-03-01
CA2329000A1 (en) 1999-11-04
ATE269712T1 (de) 2004-07-15
DE69918283T2 (de) 2005-07-21
AU3718299A (en) 1999-11-16
DK1071438T3 (da) 2004-10-25
DE69918283D1 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
PT1071438E (pt) Preparacao estabilizada de virus de herpes
FI960750A (fi) Hermon kasvutekijän farmaseuttiset formulaatiot
MX9604907A (es) Vacuna de combinacion de virus para la enfermedad de newcastle.
NZ337885A (en) vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid
NO20010576L (no) Immunologiske herpes simplex virus antigener og fremgangsmÕter for anvendelse derav
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
CY1108702T1 (el) Σκευασματα εμβολιων για τον ιο των ανθρωπινων θηλωματων
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
AU4195897A (en) Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
AU1198697A (en) Stabilizers for live vaccines
AU1271799A (en) Methods for preventing and treating bacterial infections using cellulose ace tatephthalate or hydroxypropyl methylcellulose phthalate excipients
EP0541692A4 (en) Herpes simplex virus vp16 vaccines
PT713397E (pt) Vacina que contem virus vivos
DE69928921D1 (de) Vormischungszusammensetzung zur bierklärung
WO2006071373A1 (en) Stabilization of viral compositions
AR026637A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
HUP0001991A2 (hu) Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
BR0012985A (pt) Vacina, bactéria, uso da mesma, e composição farmacêutica e métodos de tratamento ou prevenção de doença mediada por hsv em um hospedeiro humano ou animal e de uma infecção viral da mucosa de um hospedeiro humano ou animal
PT100460A (pt) Partiiculas derivadas de virus de herpes e vacinas que as contem
DK0929315T3 (da) Krydsbeskyttende equine herpesviruspræparater, deres fremstilling og anvendelse
ES2105296T3 (es) Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas.
林建安 et al. Composition of HT-7 LHCD and its Protection Systems